Collodion-like membrane in a newborn exposed to infliximab - 18/06/14
Doi : 10.1016/j.jaad.2014.01.856
Maureen Offiah, MS a, Robert T. Brodell, MD b, c, e, ⁎ 
, Leigh R. Campbell, MD d, Julie P. Wyatt, MD b
, Leigh R. Campbell, MD d, Julie P. Wyatt, MD b a School of Medicine, University of Mississippi Medical Center, Jackson
b Department of Dermatology, University of Mississippi Medical Center, Jackson
c Department of Pathology, University of Mississippi Medical Center, Jackson
d Department of Pediatrics-Neonatology, University of Mississippi Medical Center, Jackson
e Department of Dermatology, University of Rochester School of Medicine and Dentistry, New York
∗Correspondence to: Robert T. Brodell, MD, Department of Dermatology, University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216
| Funding sources: None. |
|
| Disclosure: Dr Brodell is on the speakers bureau for Allergan, Galderma, PharmaDerm (a division of Fougera Pharmaceuticals Inc), and Veregen; a consultant/investigator/advisory board member for Galderma Laboratories LP; and has performed multicenter clinical trials for Genentech and Janssen Biotech Inc. Ms Offiah and Drs Campbell and Wyatt have no conflicts of interest. |
© 2014
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 71 - N° 1
P. e22-e23 - juillet 2014 Retour au numéro
Article précédent
- Subcutaneous Sweet syndrome associated with disseminated nontuberculous mycobacterial infection leading to the diagnosis of adult-onset immunodeficiency
- Hsiao-Han Wang, Yu-Chen Huang, Wei-Yu Chen, Ying-Yi Chiang
- Reticulated hyperpigmentation following chemotherapy for radiation-induced osteosarcoma
- Catherine A. Necessary, David Roffwarg, Darrel Ellis
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?